Degrasyn is primarily used in research settings to study its potential as a therapeutic agent, particularly in cancer treatment. It functions as a deubiquitinase inhibitor, targeting and inhibiting specific enzymes involved in protein degradation pathways. This mechanism makes it a valuable tool for investigating cellular processes like apoptosis, autophagy, and protein homeostasis. Researchers are exploring its ability to induce cancer cell death by disrupting survival pathways, making it a promising candidate for developing novel anticancer therapies. Additionally, it is used in preclinical studies to understand its effects on various signaling pathways and its potential to overcome drug resistance in certain cancers.